Software That Uses Artificial Intelligence To Screen Eyes For Diabetes Damage Approved By FDA

It’s the first screening device the FDA has authorized that doesn’t need a clinician’s interpretation to look for a particular condition. In other news, the agency also is going to relax its review of next-generation sequencing tests.